TREND Releases New GM2, GM1, Canavan Community Voice Report
Our newest Community Voice Report involved some incredible people, and we are pleased to share our CVR on GM2, GM1, and Canavan. We'd like to extend our thanks to everyone who participated. We hope patients and caregivers find value in this piece.
TREND analyzed two Facebook groups for this report. One is part of the National Tay-Sachs and Allied Diseases Foundation, and the other focuses on Tanganil as a treatment. Both groups are a mixture of caregivers and patients impacted by the disease.
To read about the insights we uncovered, take a look at the CVR (totally free) here.